{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:58:22Z","timestamp":1785308302246,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Short bowel syndrome (SBS) is the main cause of intestinal failure (IF) in children, leading to severe malabsorption and dependence on parenteral nutrition (PN). The glucagon-like peptide-2(GLP-2) analogue teduglutide (TED) has emerged as the disease-specific treatment strategy capable of stimulating intestinal adaptation to promote PN reduction. In recent years, new randomized pediatric trials and growing real-world experience show that TED enables complete enteral autonomy in up to 30% of patients. This rate is much higher than the 16% reported in a 2022 systematic review of 14 pediatric studies, indicating that new research have generated different findings that can help optimize TED treatment regimens. These findings suggest that children with SBS who have significant baseline differences in PN dependence (lower PN volume, lower PN dependency index [PNDI], and fewer infusions per week) can benefit the most from teduglutide treatment. Determining the optimal timing to initiate TED for children with SBS requires individualized strategies rather than a universal recommendation. In addition, long-term administration of TED(at least one year before reassessing treatment response) is required in the treatment of SBS-IF to achieve the best therapeutic effect, which is essential for optimizing TED treatment regimens in children.<\/jats:p>","DOI":"10.3389\/fped.2026.1898958","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:58:17Z","timestamp":1785304697000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing teduglutide treatment regimens in children with short bowel syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chongqing Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s40746-019-00179-y","article-title":"Short bowel syndrome","volume":"5","author":"Shakhsheer","year":"2019","journal-title":"Curr Treat Options Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/MCO.0000000000000964","article-title":"The indications and results of the use of teduglutide in patients with short bowel","volume":"26","author":"El Khatib","year":"2023","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3390\/nu15102341","article-title":"An overview of short-bowel syndrome in pediatric patients: focus on clinical management and prevention of complications","volume":"15","author":"Caporilli","year":"2023","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clp.2012.12.003","article-title":"Short bowel syndrome in the nicu","volume":"40","author":"Amin","year":"2013","journal-title":"Clin Perinatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12328-017-0811-7","article-title":"Current treatment paradigms in pediatric short bowel syndrome","volume":"11","author":"Chandra","year":"2018","journal-title":"Clin J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1056\/NEJMra1602650","article-title":"Pediatric intestinal failure","volume":"377","author":"Duggan","year":"2017","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.dld.2019.11.013","article-title":"Understanding short bowel syndrome: current status and future perspectives","volume":"52","author":"Massironi","year":"2020","journal-title":"Dig Liver Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1080\/14656566.2024.2431291","article-title":"Use of glucagon-like polypeptide 2 analogs for intestinal failure","volume":"25","author":"Goldschmidt","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"E460","DOI":"10.1152\/ajpendo.00149.2007","article-title":"Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators","volume":"293","author":"Dube","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/jcp.30068","article-title":"Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the mlck\/pmlc signaling pathway in a piglet model","volume":"236","author":"Chang","year":"2021","journal-title":"J Cell Physiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"G211","DOI":"10.1152\/ajpgi.00530.2006","article-title":"Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2","volume":"293","author":"Sigalet","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e25S204","DOI":"10.54448\/ijn25S204","article-title":"Scientific evidence of teduglutide in parenteral support in patients with short bowel syndrome: a systematic review","volume":"18","author":"Lopes","year":"2015","journal-title":"Int J Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"112685","DOI":"10.4240\/wjgs.v17.i12.112685","article-title":"Impact of teduglutide on pediatric short bowel syndrome: a systematic review and trial sequential meta-analysis","volume":"17","author":"Jiao","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"866518","DOI":"10.3389\/fnut.2022.866518","article-title":"Use of teduglutide in children with intestinal failure: a systematic review","volume":"9","author":"Gigola","year":"2022","journal-title":"Front Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ajcnut.2023.02.019","article-title":"Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome","volume":"117","author":"Lambe","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/jcm13051238","article-title":"Evaluation of the effectiveness of teduglutide treatment in patients with short bowel syndrome in Slovakia-multicenter real-world study","volume":"13","author":"Gombo\u0161ov\u00e1","year":"2024","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.intf.2024.100027","article-title":"Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study","volume":"3","author":"Mart\u00ednez","year":"2024","journal-title":"Intest Fail"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1007\/s00431-024-05577-5","article-title":"Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study","volume":"183","author":"Germ\u00e1n-D\u00edaz","year":"2024","journal-title":"Eur J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100312","DOI":"10.1016\/j.intf.2025.100312","article-title":"Real-world efficacy of long-term teduglutide use in pediatric patients with short bowel syndrome","volume":"7","author":"Josey","year":"2025","journal-title":"Intesti Fail"},{"key":"B20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MPG.0000000000003867","article-title":"Efficacy and safety of teduglutide in infants and children with short bowel syndrome dependent on parenteral support","volume":"77","author":"Chiba","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jpn3.12276","article-title":"Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure","volume":"79","author":"Wales","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"CD8754","DOI":"10.1002\/14651858.CD008754.pub2","article-title":"Memory rehabilitation for people with multiple sclerosis","volume":"3","author":"Das Nair","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome","volume":"181","author":"Carter","year":"2017","journal-title":"J Pediatr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/jpen.1690","article-title":"Safety and efficacy of teduglutide in pediatric patients with intestinal failure due to short bowel syndrome: a 24-week, phase iii study","volume":"44","author":"Kocoshis","year":"2020","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"110642","DOI":"10.4292\/wjgpt.v16.i4.110642","article-title":"Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina","volume":"16","author":"Solar Mu\u00f1iz","year":"2025","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/MPG.0000000000002899","article-title":"Experience with teduglutide in pediatric short bowel syndrome: first real-life data","volume":"71","author":"Ramos Boluda","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MPG.0000000000003541","article-title":"The variable response to teduglutide in pediatric short bowel syndrome: a single country real-life experience","volume":"75","author":"Guz-Mark","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clnu.2025.01.026","article-title":"Real-world experience of teduglutide use in adults with short bowel syndrome: a seven-year international multicenter survey","volume":"47","author":"Joly","year":"2025","journal-title":"Clin Nutr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/ajcn\/nqy367","article-title":"The colon as an energy salvage organ for children with short bowel syndrome","volume":"109","author":"Norsa","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8460508","article-title":"Glucagon-like peptide-2 analogue zp1849 augments colonic anastomotic wound healing","volume":"2020","author":"Kjaer","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103343","DOI":"10.1016\/j.eclinm.2025.103343","article-title":"Predictors of response and enteral autonomy in children with short bowel syndrome treated with teduglutide: a real-life multicentre cohort study","volume":"85","author":"Norsa","year":"2025","journal-title":"eClinicalMed"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1016\/j.clnu.2019.12.019","article-title":"Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study","volume":"39","author":"Joly","year":"2020","journal-title":"Clin Nutr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.clnesp.2021.03.011","article-title":"Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support","volume":"43","author":"Chen","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"B36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5223\/pghn.2019.22.4.303","article-title":"Short bowel syndrome as the leading cause of intestinal failure in early life: some insights into the management","volume":"22","author":"Goulet","year":"2019","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1055\/a-2646-0683","article-title":"Reduction of parenteral nutrition in children with short bowel syndrome treated with teduglutide: experience from the Czech republic","author":"Peskova","year":"2025","journal-title":"Klin Padiatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e70301","DOI":"10.1111\/ped.70301","article-title":"Teduglutide in pediatric patients under 10\u2009kg with short bowel syndrome on parenteral support: an open-label study","volume":"68","author":"Masumoto","year":"2026","journal-title":"Pediatr Int"},{"key":"B39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00383-025-06154-z","article-title":"Three-year experience with glp-2 analog in intestinal rehabilitation for pediatric-onset short bowel syndrome","volume":"41","author":"Tazuke","year":"2025","journal-title":"Pediatr Surg Int"},{"key":"B40","doi-asserted-by":"publisher","first-page":"70023","DOI":"10.1002\/ncp.70023","article-title":"A case report on the long-term use of teduglutide in a pediatric patient with short bowel syndrome","author":"Sakurai","year":"2025","journal-title":"Nutr Clin Pract"},{"key":"B41","doi-asserted-by":"publisher","first-page":"102817","DOI":"10.1016\/j.clnesp.2025.11.132","article-title":"Positive clinical outcomes associated with use of glucagon-like peptide-2 (glp-2) analogues in patients with intestinal failure: a systematic review and meta-analysis","volume":"71","author":"Bastas","year":"2026","journal-title":"Clin Nutr ESPEN"},{"key":"B42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jpeds.2023.113882","article-title":"The impact of teduglutide on real-life health care costs in children with short bowel syndrome","volume":"20","author":"Cucinotta","year":"2023","journal-title":"J Pedia"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1898958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:58:18Z","timestamp":1785304698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1898958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":42,"alternative-id":["10.3389\/fped.2026.1898958"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1898958","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1898958"}}